Ledger.Open graph →
SEC Form D · filed August 27, 2018

Olema Pharmaceuticals, Inc

Offering
$6.1M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

CrossHarbor Institutional Partners 2021 GP, L.P · Boston, MADirectorCourtland B. Cunningham · ST. PAUL, MNExec · DirectorSamuel B. Carr, Jr · ST. PAUL, MNDirectorCatherine L. Weyerhaeuser · ST. PAUL, MNDirectorDavid Myles · San Francisco, CAExecLawrence Fritz · San Francisco, CADirectorGlen T. Kacher · Palo Alto, CAExec · DirectorRobert M. Wenzell · Palo Alto, CADirectorAdam M. Hutt · New York, NYDirectorRachael Holladay · Austin, TXDirectorDavid Myles · San Francisco, CAExecMarina Bozilenko · San Francisco, CADirectorPeter Kusher · San Francisco, CAExec · DirectorLawrence Fritz · BRISBANE, CADirectorAndrei Manoliu · Frisco, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗